AlidaBio Secures $7.5M to Optimize Epitranscriptomic Research
What You Should Know:
– Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation…
Continue Reading